Vietnam Medi-Pharm 2024
2024年5月9日至12日,越南河内医疗器械展览会盛大召开,鸿鹄科技携最新神经外科设备参展,备受瞩目。我们的创新技术和卓越品质赢得了广泛赞誉,成为现场的一大亮点。
From May 9th to 12th, 2024, the grand Vietnam Medi-Pharm was held, where Honghu Technology showcased its latest neurosurgical equipment, attracting much attention. Our innovative technology and excellent quality received wide acclaim, becoming a highlight of the event.
创新技术引领行业
Innovative Technology Leads the Industry
作为行业先锋,鸿鹄科技始终坚持以客户需求为导向,致力于研发更先进、更实用的医疗设备。我们的神经外科设备在博览会现场得到了专家们的一致好评,认为其代表了当前医疗器械领域的发展趋势。
As an industry pioneer, Honghu Technology always adheres to customer-oriented principles, dedicated to developing more advanced and practical medical equipment. Our neurosurgical devices received unanimous praise from experts at the exhibition, who believe they represent the current trend in the medical equipment field.
鸿鹄科技深知,医疗器械的核心价值在于为患者提供更好的治疗效果和更舒适的就医体验。因此,我们在产品设计上不断优化,力求让每一款设备都能体现出人性化的关怀。
Honghu Technology deeply understands that the core value of medical equipment lies in providing patients with better treatment outcomes and a more comfortable medical experience. Therefore, we continuously optimize our product designs, striving to ensure that each device reflects a humanized care approach.
卓越品质,值得信赖
Excellent Quality, Worthy of Trust
我们深知,医疗器械的质量和安全性直接关系到患者的生命安全。因此,鸿鹄科技在生产过程中严格遵循国际质量管理体系,确保每一款产品都符合最高标准。
We are well aware that the quality and safety of medical equipment are directly related to the safety of patients' lives. Therefore, Honghu Technology strictly follows international quality management systems in the production process to ensure that each product meets the highest standards.
携手鸿鹄,共创美好未来博览会期间,许多客户对我们的神经外科设备表示了强烈的合作意愿。鸿鹄科技期待与更多合作伙伴携手,共同推动医疗事业的发展,为全球患者提供更优质的医疗服务。
Join hands with Honghu to create a better future. During the exhibition, many clients expressed strong willingness to cooperate with our neurosurgical devices. Honghu Technology looks forward to partnering with more collaborators to jointly promote the development of the medical industry and provide higher quality medical services to patients worldwide.